![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
In Silico Drug Interaction of Long-acting
Rilpivirine and Cabotegravir With Rifampin
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Rajith KR Rajoli1, Paul Curley1, David Back1, Charles Flexner2, Andrew Owen1, Marco Siccardi1
1 -Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK2-Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, USA
![AASDL1](../images%20/040618/040618-2/AASDL1.gif)
![AASDL2](../images%20/040618/040618-2/AASDL2.gif)
![AASDL3](../images%20/040618/040618-2/AASDL3.gif)
![AASDL4](../images%20/040618/040618-2/AASDL4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|